T44.5X5D
ICD-10-CMAdverse effect of predominantly beta-adrenoreceptor agonists, subsequent encounter
This code signifies an undesirable or harmful reaction experienced by a patient due to the therapeutic use of a beta-agonist medication, such as those used for asthma or COPD. The "subsequent encounter" designation indicates that the patient is receiving follow-up care for this adverse effect after the initial treatment.
This code is appropriate when a patient presents for ongoing management or evaluation of an adverse effect from a beta-agonist, and the initial treatment for the adverse effect has already been provided. Examples include follow-up visits for persistent tremors, palpitations, or anxiety caused by these medications.
AI-generated reference — verify against official guidelines
+5 more in this category